[PDF][PDF] Anaphylatic reactions to biological drugs: data from spontaneous reporting in Italy

S Opri, M Zocca, A Sabaini, A Conforti, E Matarengolo… - DRUG SAFETY, 2013 - iris.univr.it
Background: Off label use is where a medicinal product is used for a medical purpose not in
accordance with the authorised product information. As a result, real-life populations using a …

Anaphylaxis: 39 Analysis of Anaphylactic Reactions to Biological Agents Reported to the Italian Pharmacovigilance Database

U Moretti, L Sottosanti, S Potenza… - The World Allergy …, 2012 - ncbi.nlm.nih.gov
Background Spontaneous reporting of adverse drug reactions (ADR) to biological agents
used for cancer and immuno-mediated disease treatment is important for furthering …

Drug-induced anaphylaxis: case/non-case study based on an Italian pharmacovigilance database

R Leone, A Conforti, M Venegoni, D Motola, U Moretti… - Drug safety, 2005 - Springer
Objective: To identify the number of cases of anaphylaxis reported in association with
different classes of drugs and compare it with other reports contained in the same database …

Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority

I Ribeiro-Vaz, J Marques, P Demoly, J Polónia… - European journal of …, 2013 - Springer
Purpose Anaphylaxis is a potentially fatal systemic adverse drug reaction (ADR). It is an
unpredictable and mostly dose-independent event that occurs suddenly following exposure …

Validity of hospital ICD‐10‐GM codes to identify anaphylaxis

D de Sordi, S Kappen, F Otto‐Sobotka… - … and Drug Safety, 2021 - Wiley Online Library
Purpose Anaphylaxis (ANA) is an important adverse drug reaction. We examined positive
predictive values (PPV) and other test characteristics of ICD‐10‐GM code algorithms for …

Analysis of Inclisiran in the US FDA Adverse Event Reporting System (FAERS): a focus on overall patient population and sex-specific subgroups

YB He, X Guan, YY Zhang, Z Zhu… - Expert Opinion on …, 2024 - Taylor & Francis
Background Our study aimed to identify inclisiran-related adverse events (AEs) for primary
hypercholesterolemia and arteriosclerotic cardiovascular disease (ASCVD) from the US …

[HTML][HTML] Drug-induced anaphylaxis: National database analysis

O Butranova, S Zyryanov, A Gorbacheva, I Asetskaya… - Pharmaceuticals, 2024 - mdpi.com
(1) Background: National health system databases represent an important source of
information about the epidemiology of adverse drug reactions including drug-induced …

Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre

C Nicol, F Moulis, E Bondon-Guitton, G Durrieu… - Therapies, 2019 - Elsevier
Summary Introduction In France since 2011, report of adverse drug reactions (ADRs) has
been extended to patients (and patients' associations) who can declare directly ADRs to …

Safety of inulin and sinistrin: combining several sources for pharmacovigilance purposes

TV Bui, C Prot-Bertoye, H Ayari, S Baron… - Frontiers in …, 2021 - frontiersin.org
Introduction: Inulin and its analog sinistrin are fructose polymers used in the food and
pharmaceutical industries. In 2018, The French National Agency for the Safety of Medicines …

Retrospective Analysis of Patient-Reported Adverse Drug Reactions in an Italian Allergy Unit: ALLERG-RAF Study

A Abate, E Rossini, M Tamburello, D Paganotti… - Pharmacology, 2024 - karger.com
Abstract Introduction: The Italian Medicines Agency indicates that about 5% of hospital
admissions are due to adverse drug reactions (ADRs). Several factors are recognized to be …